How to Get Humira (adalimumab) Covered by Humana in Michigan: Complete 2025 Guide with Forms and Appeals
Quick Answer: Humana requires prior authorization for Humira (adalimumab) in Michigan, with step therapy mandating trials of preferred biosimilars first. Submit PA via Humana's provider portal with diagnosis documentation, biosimilar failure records, and TB/hepatitis B screening. If denied, you have 65 days to appeal, with Michigan's DIFS external review available within 127 days for non-Medicare plans. Start by gathering your medical records and calling your prescriber today.
Table of Contents
- Coverage Requirements at a Glance
- Step-by-Step: Fastest Path to Approval
- Common Denial Reasons & Solutions
- Appeals Process for Michigan Residents
- Cost-Saving Strategies
- When to Escalate
- Frequently Asked Questions
Coverage Requirements at a Glance
| Requirement | What It Means | Where to Find It | Source |
|---|---|---|---|
| Prior Authorization Required | Must get approval before filling | Humana formulary/provider portal | Humana PA Lists |
| Step Therapy | Try biosimilars (Amjevita, Cyltezo) first | Part B step therapy policy | 2024 Step Therapy List |
| TB/Hepatitis B Screening | Required before starting | Lab results in PA submission | FDA Humira Label |
| Appeals Deadline | 65 days from denial notice | Medicare Part D regulations | CMS Appeals Process |
| Michigan External Review | 127 days after final denial | DIFS external review form | Michigan DIFS Appeals |
Step-by-Step: Fastest Path to Approval
1. Verify Your Plan Type and Coverage
Who: Patient
Timeline: Same day
Action: Call the number on your Humana ID card to confirm whether you have Medicare Advantage, Medicare Part D, or commercial coverage. Ask specifically about Humira's formulary status and PA requirements.
2. Gather Required Documentation
Who: Patient and prescriber
Timeline: 1-2 weeks
Documents needed:
- Complete medical records with diagnosis and ICD-10 codes
- Documentation of biosimilar trials (Amjevita, Cyltezo) with dates, doses, and failure reasons
- Recent lab results: TB screening (QuantiFERON-Gold), hepatitis B panel (HBsAg, HBcAb)
- Current disease activity measures (for RA: DAS28, CDAI; for IBD: Mayo score, CDAI)
3. Document Biosimilar Step Therapy
Who: Prescriber
Timeline: Must show adequate trials
Requirements: Per Humana's step therapy policy, document failure, intolerance, or contraindication to preferred adalimumab biosimilars. Include specific dates, dosing, duration of trials, and reasons for discontinuation.
4. Submit Prior Authorization
Who: Prescriber or clinic staff
Timeline: Allow 72 hours for standard decision
Method: Submit via Humana provider portal or call 800-457-4708
Include: Complete PA form, medical necessity letter, all supporting documentation
5. Request Expedited Review if Urgent
Who: Prescriber
Timeline: 24-72 hours for decision
Criteria: If waiting could seriously harm your health, have your doctor submit a letter stating medical urgency with the PA request.
6. Monitor Decision and Prepare for Appeals
Who: Patient and clinic
Timeline: Track submission date
Action: If no response within 72 hours for standard requests, follow up. If denied, immediately request peer-to-peer review and prepare appeal documentation.
Common Denial Reasons & Solutions
| Denial Reason | How to Overturn | Required Documentation |
|---|---|---|
| Step therapy not completed | Document biosimilar failures | Trial dates, doses, specific adverse effects or lack of efficacy |
| Missing safety screening | Submit required lab results | QuantiFERON-Gold, hepatitis B panel, CBC, liver function tests |
| Insufficient medical necessity | Strengthen clinical justification | Disease activity scores, functional assessments, treatment goals |
| Non-formulary status | Request formulary exception | Medical necessity letter citing why biosimilars inappropriate |
| Quantity limits exceeded | Justify dosing rationale | Weight-based dosing calculations, clinical guidelines |
Clinician Corner: Medical Necessity Letter ChecklistPatient's specific diagnosis with ICD-10 codesCurrent disease activity and functional statusPrior therapies tried with specific dates, doses, and outcomesContraindications or allergies to preferred alternativesClinical guidelines supporting Humira use (ACR for RA, AGA for IBD)Monitoring plan and treatment goalsFDA labeling references for approved indications
Appeals Process for Michigan Residents
Internal Appeals (Humana)
Timeline: File within 65 days of denial notice
Decision: 7 calendar days (standard) or 72 hours (expedited)
Method: Submit to Humana Grievances and Appeals, P.O. Box 14546, Lexington, KY 40512-4546 or call member services
Peer-to-Peer Review
When: Request immediately upon denial
Process: Your prescriber calls Humana's medical director
Success rate: 80-85% overturn rate when properly documented
Preparation: Have failure documentation, clinical guidelines, and treatment rationale ready
Michigan External Review (Non-Medicare Plans)
Timeline: 127 days after final internal denial
Process: Submit DIFS External Review Form FIS 0018
Decision: Up to 60 days (72 hours if expedited)
Contact: Michigan DIFS at 877-999-6442
Note: Medicare Advantage and Part D plans follow federal appeals processes, not Michigan's DIFS external review. Verify your plan type before choosing your appeal path.
Cost-Saving Strategies
While Medicare patients cannot use manufacturer copay cards, several assistance options exist:
For Non-Medicare Patients
- AbbVie Complete Savings Program: Up to $5 copays (verify current terms at AbbVie.com)
- Patient assistance programs: Income-based free drug programs
For All Patients
- Medicare Extra Help: Low-income subsidy program
- HealthWell Foundation: Grants for specialty medications
- State pharmaceutical assistance programs: Michigan may offer additional support
At Counterforce Health, we help patients navigate these complex coverage decisions by turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and plan policies to identify the specific reasons for denial and drafts point-by-point rebuttals aligned with your plan's own rules.
When to Escalate
Contact Michigan regulators if:
- Humana violates appeal timelines
- You believe the denial violates state insurance laws
- Internal appeals are repeatedly denied without clear justification
Michigan DIFS Contact:
Phone: 877-999-6442
Website: michigan.gov/difs
Frequently Asked Questions
How long does Humana prior authorization take in Michigan?
Standard PA decisions are made within 72 hours. Expedited reviews for urgent cases are completed within 24-72 hours when medical urgency is documented.
What if Humira is non-formulary on my Humana plan?
Request a formulary exception by documenting medical necessity and why preferred alternatives (biosimilars) are inappropriate. Include allergy documentation or prior failure records.
Can I request an expedited appeal in Michigan?
Yes, if waiting for a standard decision could seriously harm your health. Your doctor must provide written documentation of the medical urgency.
Does step therapy apply if I was stable on Humira before joining Humana?
You may qualify for a transition fill (up to 90 days) if you have recent claims showing successful Humira use. Document this with your PA submission.
What's the success rate for Humana appeals in Michigan?
Properly documented appeals citing relevant coverage policies achieve 72-80% overturn rates, with peer-to-peer reviews showing even higher success rates.
How much does Humira cost with Humana coverage?
Costs vary by plan tier. Humira typically falls on the highest specialty tier with copays ranging from $636-$1,513 per fill until you reach the annual out-of-pocket maximum of $2,000 for Medicare Part D.
Can my doctor help with the appeal process?
Yes, your prescriber can file appeals on your behalf with written consent and should participate in peer-to-peer reviews when requested by Humana's medical team.
From Our Advocates: We've seen patients succeed by staying organized and persistent. One Michigan patient with rheumatoid arthritis had their initial Humira denial overturned within two weeks by documenting specific allergic reactions to biosimilar inactive ingredients and providing detailed rheumatologist notes. The key was having complete documentation ready before the appeal deadline.
Sources & Further Reading
- Humana Prior Authorization Lists
- Humana Part B Step Therapy Policy 2024
- Michigan DIFS External Review Process
- CMS Medicare Part D Appeals Flowchart
- FDA Humira Prescribing Information
Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual circumstances and plan terms. Always consult with your healthcare provider and insurance plan directly for coverage determinations. For additional assistance with insurance appeals and coverage decisions, Counterforce Health provides specialized support in turning denials into successful appeals through evidence-based advocacy.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.